Hearn Jay Cho, MD, PhD
img_Hearn Jay Cho
CLINICAL PROFESSOR | Medicine, Hematology and Medical Oncology
CLINICAL PROFESSOR | Immunology & Immunotherapy
Are you a patient?
Specialties
Hematology-Oncology, Cancer (Oncology)
Multi-Disciplinary Training Area
Disease Mechanisms and Therapeutics (DMT)

MD, Weill Medical College of Cornell University

Residency, Internal Medicine, University of California Medical Center San Diego

Fellowship, Hematology & Oncology, New York Presbyterian Hospital-Weill Cornell

Publications

Selected Publications

Longitudinal Profiling of Tumor and Immune Compartments Uncovers Patterns of Dysregulation and Associations with Response in Multiple Myeloma. Denis J. Ohlstrom, William C. Pilcher, Marina E. Michaud, Chaitanya Acharya, Sarthak Satpathy, Edgar Gonzalez-Kozlova, Reyka G. Jayasinghe, Katherine Ferguson, Hope L. Mumme, Shivani Nanda, Yizhe Song, Sowmitri Mantrala, Dimitra Karagkouni, Jessica Schulman, Nick Pabustan, Junia Vieira Dos Santos, Daniel W. Sherbenou, Jonathan J. Keats, Alexander M. Gout, Steven Foltz, Alessandro Lagana, Taxiarchis Kourelis, Ravi Vij, Madhav V. Dhodapkar, David Avigan, Hearn Jay Cho, Linda B. Baughn, Ajay K. Nooka, Sagar Lonial, Shaji Kumar, Mehmet K. Samur, Ioannis S. Vlachos, Li Ding, Sacha Gnjatic, George Mulligan, Manoj K. Bhasin. Blood cancer discovery

Long-term remission after cilta-cel in multiple myeloma is linked to diverse T cells and low myeloid suppression. Junia Vieira dos Santos, David T. Melnekoff, Adolfo Aleman, Tarek H. Mouhieddine, Rocio Montes de Oca, Feng Wang, Sridevi Rajeeve, Sherry Bhalla, Oliver Van Oekelen, Bhaskar Upadhyaya, Yogita Ghodke-Puranik, Violetta Leshchenko, Seunghee Kim-Schulze, Adeeb Rahman, Shaked Afik, Hadas Lewinsky, Vicki Plaks, Santiago Thibaud, Hearn Jay Cho, Joshua Richter, Cesar Rodriguez, Larysa Sanchez, Adriana Rossi, Shambavi Richard, Ajai Chari, Deepu Madduri, Sundar Jagannath, Samir Parekh, Alessandro Laganà. Blood advances

Financial Toxicity and Satisfaction With Cancer Treatment Among Patients With Multiple Myeloma: An Analysis of the MMRF's CureCloud Initiative. Mark A. Fiala, Eva Lepisto, Chioma Amadi-Mgbenka, Jessica Schulman, George Mulligan, Hearn Jay Cho. Clinical Lymphoma, Myeloma and Leukemia

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Cho during 2025 and/or 2026. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Guidepoint

Outside Employment

  • Multiple Myeloma Research Foundation (MMRF)

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.